Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: Analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) Trial
- Helmut Schühlen
- , Martin Hadamitzky
- , Hanna Walter
- , Kurt Ulm
- , Albert Schömig
- Technical University of Munich
Research output: Contribution to journal › Article › peer-review
96
Scopus
citations